06/08/2026
FYI
5 conditions where the research tells a story conventional medicine hasn't fully caught up to yet. 🔬
Let's get one thing straight: this isn't about getting high. This is about peer-reviewed, double-blind, placebo-controlled science. Here's what the data actually says.
1️⃣ CHRONIC NEUROPATHIC PAIN
Two major meta-analyses - one covering 32 trials, another covering 36 - found that cannabinoids produce small but meaningful reductions in chronic pain. Some studies even point to patients leaning on opioids less, though researchers are honest that this part needs more study. (Wang et al., BMJ 2021)
2️⃣ TREATMENT-RESISTANT EPILEPSY
This is the big one. In randomized, double-blind, placebo-controlled trials, CBD significantly reduced seizures in patients with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex - kids and adults for whom standard meds had ALREADY failed. This research is exactly why the FDA approved a CBD-based medication (Epidiolex). That's not alternative medicine. That's a last resort that actually worked. (Devinsky et al., NEJM 2017 & 2018; Thiele et al., Lancet 2018 & JAMA Neurology 2021)
3️⃣ MS SPASTICITY
A 1:1 THC/CBD oromucosal spray (Sativex) earned full regulatory approval in the UK and Germany specifically for multiple sclerosis spasticity - for patients whom conventional muscle relaxants had left without adequate relief. A government approved it. (Novotna et al., European Journal of Neurology 2011)
4️⃣ PTSD
In Israel's national medical cannabis program - one of the most established on earth - a PTSD patient can only be approved AFTER they've already failed at least two medications AND two psychological therapies. It's not the first option. It's what's tried when nothing else works. (Israeli Ministry of Health guidelines)
5️⃣ OPIOID DEPENDENCE
A 2025 study of New York State medical cannabis patients found that chronic pain patients who added medical cannabis reduced their daily opioid dose by 22% over 18 months. Cannabis didn't just treat the pain - it helped some people lean less on the very drug that's fueling a national crisis. (Slawek et al., JAMA Internal Medicine 2025)
Five conditions. Real studies. Peer-reviewed data. 🧪
And here is the ultimate irony: Because researching cannabis on U.S. soil has historically been a bureaucratic nightmare, the United States Government (via the National Institutes of Health) actually funded the foundational Israeli cannabis research for nearly 50 years. American tax dollars paid for the science that other countries now use to treat their citizens.
The narrative that cannabis has "no medical value" was never about the science. The science was always there.
We're not telling you what to do. We're just telling you what the research says - because you deserve to make an informed decision.
Questions? That's literally what we're here for. Come talk to us and ask questions.
📚 The sources, because we don't make claims we can't back up:
• Pain: Wang et al., BMJ 2021 - bmj.com/content/374/bmj.n1034 • Epilepsy: Devinsky et al., NEJM 2017 - pubmed.ncbi.nlm.nih.gov/28538134
• MS: Novotna et al., Eur J Neurol 2011 - pubmed.ncbi.nlm.nih.gov/21362108
• PTSD: Israeli Ministry of Health medical cannabis guidelines
• Opioids: Slawek et al., JAMA Internal Medicine 2025 - jamanetwork.com/journals/jamainternalmedicine/fullarticle/2842414
📍 KY CBD Farmacy | 228 Jane Trail, Danville, KY 💻 www.kycbdfarmacy.com 🚚 Free Next Day Delivery on $50+
